f8k071812_patientsafety.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 8-K
 
 
Current Report
 
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): July 18, 2012
 
 
Patient Safety Technologies Inc.
(Exact Name of Registrant as Specified in Charter)
 
 
Delaware
  
001-09727
  
13-3419202
(State or Other Jurisdiction
of Incorporation)
  
Commission File Number
  
(IRS Employer
Identification No.)
 
2 Venture Plaza, Suite 350, Irvine, CA
  
92618
(Address of Principal Executive Offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (949) 387-2277
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 5.07
Submission of Matters to a Vote of Security Holders
 
The voting results for the matters submitted to a vote of our stockholders at our Annual Meeting of Stockholders held on July 18, 2012, which are described in detail in our proxy statement filed with the Securities and Exchange Commission on June 27, 2012, are as follows:
 
1A.
Directors elected to serve until our 2013 annual meeting of stockholders by the holders of our common stock and Series A Preferred Stock voting together as a single class:
 
   
For
    
Withheld
  
John P. Francis
   21,409,507     1,713,626  
Wenchen Lin
   22,135,415     987,718  
Brian E. Stewart
   22,143,515     979,618  
 
1B.
Directors elected to serve until our 2013 annual meeting of stockholders by the holders of our Series A Preferred Stock:
 
   
For
    
Withheld
  
Louis Glazer, M.D., Ph.G.
   8,250     -0-  
Lynne Silverstein
   8,250     -0-  
 
2.
Ratification of the appointment of Squar, Milner, Peterson, Miranda & Williamson, L.L.P. as our independent registered public accounting firm for the fiscal year ending December 31, 2012:
 
For
    
Against
    
Abstain
    
Broker Non-votes
  
 23,089,342      11,811      38,800      --  
 
3.
Amendment of our Amended and Restated Certificate of Incorporation to change the par value of our common stock from $0.33 to $0.0001:
 
For
    
Against
    
Abstain
    
Broker Non-votes
  
 22,959,015      133,048      31,070      --  
 
4.
Amendment of our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock:
 
For
    
Against
    
Abstain
    
Broker Non-votes
  
 21,858,306      1,237,937      26,890      --  
 
5.
Amendment of the Patient Safety Technologies, Inc. 2009 Stock Option Plan to increase the number of shares issuable under the Plan from 3,000,000 to 4,500,000 and to clarify the non-discretionary nature of the share limit on annual grants:
 
For
    
Against
    
Abstain
    
Broker Non-votes
  
 22,129,387      946,281      47,465      --  

 
2
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Patient Safety Technologies, Inc.
  
       
Dated: July 23, 2012
By:
/s/ DAVID C. DREYER
  
   
David C. Dreyer
  
   
Executive Vice President, Chief Financial Officer, and Secretary
  

 
3